Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


Payer Strategies for Emerging Markets

30 Jul 2013 - 01 Aug 2013 - Philadelphia, PA, USA



Bookmark and Share


Emerging markets are moving up the agenda of pharma and global healthcare organizations. Yet many regions are still unchartered territory and are difficult to navigate. To build effective strategic partnerships and drive the most profitable performance, you need to understand the dynamics that make these regions so challenging, yet full of potential...

That means the payers. What they need.  How they need it.  When they need it.

Payer Strategies for Emerging Markets will set you up to execute the most successful product launches in the world’s key growth markets.  Learn to manage the transformation of your traditional pharmaceutical business model to one that really takes hold in the world’s key growth economies.

This meeting will provide you with the clarity you need to demonstrate maximum product value to payers in emerging markets. The agenda has been designed in collaboration with leaders from organizations like Pfizer, Abbott, World Bank, Novartis, Merck and the World Health Organization.

Build solid payer-industry partnerships at this highly interactive forum. Payer Strategies for Emerging Markets was created for you to meet the key stakeholders who can give you the gold standard business intelligence to adapt your market access approach in different regions.

Meet pharma, payer organizations and key solution providers. This meeting lets you use these relationships to refine your product launch strategy and strengthen the foundation for commercial success in emerging markets.

At the meeting you will…

Gain an insight into regional price containment strategies. Avoid the hurdles to maximize impact at product launch

Ensure maximum patient compliance.  Find out how to best engage with an out of pocket payer in a changing health economic environment

Keep early value demonstration front of mind when preparing healthcare authorities for your product hitting the market

Develop actionable pricing and reimbursement strategies for streamlined access in emerging markets

Adapt your marketing approach and design your distribution strategies to meet the needs of both the public and private payer for long-term, regional, profitable success

Discover the benefits of local and corporate team integration to avoid a culture clash when accessing emerging markets

Understand the importance of a clear launch strategy for optimal product development and distribution in emerging markets

Payer Strategies for Emerging Markets will equip you with the knowledge and tools to boost business in key growth economies.  Get an understanding of the payers and develop unique strategies to adapt and optimize your access approach in emerging markets.

Who you’ll meet…

Pharmaceutical Companies: Heads of Marketing, Pricing, Reimbursement, Medical Affairs and Market Access looking to partner with payers and plan developers to optimize reimbursement and build strategic relationships

Payers and Plan Developers: Group Directors and Managers looking to gain a more thorough understanding of the access and pricing environment and form strategic partnerships with pharma

Market Access Consultancies: Vice President of Sales and Marketing and Directors of Business Development keen to generate new business, successfully collaborate with industry leaders and stay front-of-mind when pharma look to source consultants




Further information
Scientific News
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
`Molecular Commando’ Identified to Tackle Hypoxia Pathway
Scientists identify 'molecular commando' that can activate hypoxic response, which helps combat a number of conditions.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Two Antibiotics Fight Bacteria Differently Than Thought
Researchers discover that two widely prescribed antibiotics may fight bacteria differently than previously thought.
Drug Target for Gastrointestinal Stromal Tumors Identified
Researchers show the Hedgehog signaling pathway is central to the formation of gastrointestinal stromal tumors.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!